ISCHEMIA: Invasive therapy no better than meds for reducing CV events

People with severe but stable ischemic heart disease (SIHD) don’t benefit any more from invasive CV procedures than they do from optimal medical therapy (OMT) and lifestyle changes alone, according to results from the highly anticipated ISCHEMIA trial.

X